Cutting edge findings from multiple sclerosis experts!

The 6th annual ACTRIMS Forum was held virtually, on February 25-27, 2021.
Themed The Spectrum of Multiple Sclerosis, the meeting featured the latest scientific discoveries and translational research in the field of MS.

Browse our coverage by topic to find incredible updates on MS biomarkers, pathology, treatments and more!

View all videos

ACTRIMS Forum 2021

Virtual Meeting, 25-27 February 2021

ACTRIMS Forum 2021

Virtual Meeting, 25-27 February 2021

Cutting edge findings from multiple sclerosis experts!

The 6th annual ACTRIMS Forum was held virtually, on February 25-27, 2021.
Themed The Spectrum of Multiple Sclerosis, the meeting featured the latest scientific discoveries and translational research in the field of MS.

Browse our coverage by topic to find incredible updates on MS biomarkers, pathology, treatments and more!

View all videos

Latest videos from ACTRIMS 2021

View all
1:33
Constrained social networks are associated with worse physical functioning in MS
Claire Riley • 26 Feb 2021
4:21
Moving towards precision medicine in MS with sNfL
Mark Freedman • 3 Mar 2021
5:05
Infusion of young CSF improves memory function in aged mice
Tal Iram • 4 Mar 2021
3:11
CNM-Au8 gold nanocatalysts to slow disease progression in ALS
Robert Glanzman • 1 Mar 2021

Biology

View all
3:07
Investigating remyelination with apo-transferrin and triiodothyronine
Jorge Correale • 5 Mar 2021
2:06
MS across the lifespan: menopause and hormonal effects
Rhonda Voskuhl • 25 Feb 2021
3:11
Adiponectin induces pro-inflammatory immune activation in pediatric-onset MS
Amit Bar-Or • 25 Feb 2021
2:11
Leukocyte telomere length and disability in MS
Jennifer Graves • 27 Feb 2021

Treatment

View all
3:11
CNM-Au8 gold nanocatalysts to slow disease progression in ALS
Robert Glanzman • 1 Mar 2021
4:18
Determining the optimal treatment strategy in MS
Tanuja Chitnis • 23 Feb 2021
1:39
DMT use and clinical characteristics in MS by race and ethnicity
Carlos Pérez • 25 Feb 2021
6:13
Estrogen treatments to negate menopausal effects on disability severity in women with MS
Rhonda Voskuhl • 25 Feb 2021

Biomarkers

View all
4:21
Moving towards precision medicine in MS with sNfL
Mark Freedman • 3 Mar 2021
3:13
Challenges in treating aging: public acceptance and biomarkers
Tal Iram • 4 Mar 2021
2:33
Predicting benign disease course in MS
Mark Freedman • 3 Mar 2021
4:48
Serum neurofilament light chain levels as a biomarker in MS
Elias Sotirchos • 23 Feb 2021
The content of VJNeurology is intended for healthcare professionals